Institute seminar February 27th Guro Elisabeth Lind

Skourti E, Seip K, Mensali N, Jabeen S, Juell S, Øynebråten I, Pettersen S, Engebraaten O, Corthay A, Inderberg EM, Dolznig H, Mælandsmo GM, Egeland EV, Prasmickaite L (2025)
Chemoresistant tumor cell secretome potentiates immune suppression in triple negative breast cancer
Breast Cancer Res, 27 (1), 131
DOI 10.1186/s13058-025-02082-x, PubMed 40660361

Lystad AH (2025)
V-ATPase assembly at leaky lysosomes
Nat Struct Mol Biol (in press)
DOI 10.1038/s41594-025-01612-7, PubMed 40646311

Patel D, Tiusanen V, Karttunen K, Pihlajamaa P, Sahu B (2025)
Cancer cell type-specific derepression of transposable elements by inhibition of chromatin modifier enzymes
Commun Biol, 8 (1), 992
DOI 10.1038/s42003-025-08413-0, PubMed 40610675

Chen Y, He L, Ianevski A, Nader K, Ruokoranta T, Linnavirta N, Miettinen JJ, Vähä-Koskela M, Vänttinen I, Kuusanmäki H, Kontro M, Porkka K, Wennerberg K, Heckman CA, Giri AK, Aittokallio T (2025)
A Machine Learning-Based Strategy Predicts Selective and Synergistic Drug Combinations for Relapsed Acute Myeloid Leukemia
Cancer Res, 85 (14), 2753-2768
DOI 10.1158/0008-5472.CAN-24-3840, PubMed 40354625

Skourti E, Seip K, Mensali N, Jabeen S, Juell S, Øynebråten I, Pettersen S, Engebraaten O, Corthay A, Inderberg EM, Dolznig H, Mælandsmo GM, Egeland EV, Prasmickaite L (2025)
Chemoresistant tumor cell secretome potentiates immune suppression in triple negative breast cancer
Breast Cancer Res, 27 (1), 131
DOI 10.1186/s13058-025-02082-x, PubMed 40660361

Lystad AH (2025)
V-ATPase assembly at leaky lysosomes
Nat Struct Mol Biol (in press)
DOI 10.1038/s41594-025-01612-7, PubMed 40646311